Delivery Order SPE2DB24D2101-SPE2DB25FKPGU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,592.97 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The product will be delivered to the company's Conshohocken, Pennsylvania location, which serves as the place of performance for this transaction. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections, with a ceiling value of $1,738.69 and an ultimate completion date of August 18, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $13,775.88 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pens on August 19, 2025, with completion scheduled for August 20, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a single-line pharmaceutical procurement supporting federal medical supply requirements. The order is being performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $14,113.92 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens with a completion date of September 3, 2025. This competitively awarded, firm fixed-price contract is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The point of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,379.27 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed price delivery order is issued without set-aside status, indicating competitive award based on open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens valued at $7,129.50. This is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and no set-aside designation was used in the award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. As a competitively awarded contract, this order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injections with a ceiling value of $1,088.36. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 11, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's capability to compete in open...
- The Defense Logistics Agency awarded a delivery order valued at $2,573.79 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens on August 13, 2025, with completion scheduled for August 14, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement within AmerisourceBergen's broader federal contract portfolio. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injections valued at $7,989.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injections, with a contract value of $6,577.97 and a completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was issued on July 31, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this order, which falls under the company's existing...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPGUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pens on September 8, 2025, with a ceiling value of $1,904.63 and firm fixed pricing. This non-set-aside, competitively awarded contract represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a wide range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The Mounjaro order exemplifies the company's role in delivering specialty medications through the DLA's Medical Supply Chain to support Defense Health Agency and other federal healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/8/25 |